Ironwood Pharmaceuticals IRWD Intangibles (Net)
Intangibles (Net) at other companies
Other financials
Where this comes from
Reported directly by Ironwood Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:FiniteLivedIntangibleAssetsNet.
The official record: Ironwood Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Ironwood Pharmaceuticals's intangibles (net).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Ironwood Pharmaceuticals's intangibles (net)?
- Ironwood Pharmaceuticals (IRWD) reported intangibles (net) of $1.84M in Q1 2026.
- How has Ironwood Pharmaceuticals's intangibles (net) changed year-over-year?
- Ironwood Pharmaceuticals's intangibles (net) decreased by 30.9% year-over-year, from $2.66M to $1.84M.
- What is the long-term trend for Ironwood Pharmaceuticals's intangibles (net)?
- Over 2 years (2023 to 2025), Ironwood Pharmaceuticals's intangibles (net) has grown at a -25.6% compound annual growth rate (CAGR), from $3.68M to $2.04M.
- What does intangibles (net) mean?
- Identifiable intangible assets (patents, trademarks, customer relationships, technology) net of accumulated amortization — excluding goodwill.